Allos Therapeutics, Inc. to Present At the U.S. Bancorp Piper Jaffray Health Care Conference in New York
(PR Newswire)...The presence of oxygen in tumors is an essential element for the effectiveness of radiation therapy and some chemotherapy in the treatment of cancer.......Unlike chemotherapeutics or other radiosensitizers, RSR13 does not have to cross the blood brain barrier and enter the tumor for efficacy....- Jan 26 12:17 PM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/prnews/010126/co_allos_t.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines